Scott D. Mosser

Selective Inhibition of <i>ras</i> -Dependent Transformation by a Farnesyltransferase Inhibitor

Nancy E. Kohl, Scott D. Mosser, S. J. DESOLMS et al. · Science · 1993 · 582 citations

Medicine, Oncology, Pharmacology +13

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

Nancy E. Kohl, Charles A. Omer, Michael W. Conner et al. · Nature Medicine · 1995 · 539 citations

Medicine, Cancer Biology, Oncology +11

Steady-state kinetic mechanism of ras farnesyl:protein transferase

David L. Pompliano, Elaine Rands, Michael D. Schaber et al. · Biochemistry · 1992 · 246 citations · Full text

Life Sciences, Biochemistry, Biocatalysis +16

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

Rebecca E. Barrington, Mark A. Subler, Elaine Rands et al. · Molecular and Cellular Biology · 1998 · 172 citations

Medicine, Oncology, Pharmacology +16

Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine:  Discovery of <i>N</i> -[(3 <i>R</i> ,6 <i>S</i> )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 <i>H</i> -imidazo[4,5- <i>b</i> ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974)

Daniel V. Paone, Anthony W. Shaw, Diem N. Nguyen et al. · Journal of Medicinal Chemistry · 2007 · 146 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17